Histopathological regression after taxane based neoadjuvant chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma.

Sorry, there's nothing here.

Cite this paper

@article{Mitra2017HistopathologicalRA, title={Histopathological regression after taxane based neoadjuvant chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma.}, author={Abhishek Mitra and Shailesh Vinayak Shrikhande and Bhawna Sirohi}, journal={Translational gastroenterology and hepatology}, year={2017}, volume={2}, pages={46} }